JP2023510835A5 - - Google Patents

Info

Publication number
JP2023510835A5
JP2023510835A5 JP2022542655A JP2022542655A JP2023510835A5 JP 2023510835 A5 JP2023510835 A5 JP 2023510835A5 JP 2022542655 A JP2022542655 A JP 2022542655A JP 2022542655 A JP2022542655 A JP 2022542655A JP 2023510835 A5 JP2023510835 A5 JP 2023510835A5
Authority
JP
Japan
Prior art keywords
alkyl
compound according
cycloalkyl
substituted
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022542655A
Other languages
English (en)
Japanese (ja)
Other versions
JP7728265B2 (ja
JP2023510835A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/071381 external-priority patent/WO2021143706A1/en
Publication of JP2023510835A publication Critical patent/JP2023510835A/ja
Publication of JP2023510835A5 publication Critical patent/JP2023510835A5/ja
Application granted granted Critical
Publication of JP7728265B2 publication Critical patent/JP7728265B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022542655A 2020-01-13 2021-01-13 甲状腺ホルモン受容体アゴニストとしての置換トリアジノン Active JP7728265B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2020071741 2020-01-13
CNPCT/CN2020/071741 2020-01-13
CN2020107757 2020-08-07
CNPCT/CN2020/107757 2020-08-07
PCT/CN2021/071381 WO2021143706A1 (en) 2020-01-13 2021-01-13 Substituted triazinones as thyroid hormone receptor agonists

Publications (3)

Publication Number Publication Date
JP2023510835A JP2023510835A (ja) 2023-03-15
JP2023510835A5 true JP2023510835A5 (cg-RX-API-DMAC7.html) 2024-01-25
JP7728265B2 JP7728265B2 (ja) 2025-08-22

Family

ID=74418122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022542655A Active JP7728265B2 (ja) 2020-01-13 2021-01-13 甲状腺ホルモン受容体アゴニストとしての置換トリアジノン

Country Status (9)

Country Link
US (3) US11780825B2 (cg-RX-API-DMAC7.html)
EP (1) EP4090652A1 (cg-RX-API-DMAC7.html)
JP (1) JP7728265B2 (cg-RX-API-DMAC7.html)
CN (1) CN115244037B (cg-RX-API-DMAC7.html)
AU (1) AU2021208027B2 (cg-RX-API-DMAC7.html)
IL (1) IL294494A (cg-RX-API-DMAC7.html)
MX (1) MX2022008626A (cg-RX-API-DMAC7.html)
WO (1) WO2021143706A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202207541B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020227549A1 (en) 2019-05-08 2020-11-12 Aligos Therapeutics, Inc. MODULATORS OF THR-β AND METHODS OF USE THEREOF
MX2022008626A (es) 2020-01-13 2022-08-22 Eccogene Shanghai Co Ltd Triazinonas sustituidas como agonistas del receptor de la hormona tiroidea.
EP4168384A4 (en) 2020-06-17 2024-07-10 Autobahn Therapeutics, Inc. THYROMIMETICS
EP4167986A4 (en) 2020-06-17 2024-11-20 Autobahn Therapeutics, Inc. THYROMIMETICS
JP2023549332A (ja) * 2020-11-06 2023-11-24 アリゴス セラピューティクス,インコーポレーテッド 甲状腺ホルモン受容体調節剤としての2-ピリドン
CN114685450B (zh) * 2020-12-30 2026-06-16 昆药集团股份有限公司 2-吡啶酮类衍生物及其制备方法和在医药上的应用
CN117624069A (zh) * 2022-08-19 2024-03-01 凯思凯迪(上海)医药科技有限公司 一种多环类甲状腺激素β受体激动剂及其用途
CN118146123A (zh) * 2024-02-04 2024-06-07 河北鼎泰制药有限公司 一种盐酸安罗替尼中间体的合成方法
WO2026067791A1 (en) * 2024-09-30 2026-04-02 Ascletis Pharma (China) Co., Limited 2-phenyl-1,2,4-triazine-3,5(2h,4h)-dione derivatives as thr-beta agonist or modulators for the treatment of obesity
WO2026092583A1 (en) 2024-10-30 2026-05-07 Ascletis Pharma (China) Co., Limited Thr-beta modulators, alone or in combination with glp-1r\gipr\gcgr modulators for the treatment of metabolic diseases and alopecia areata diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
DE60020786T2 (de) 1999-09-30 2006-03-23 Pfizer Products Inc., Groton 6-Azauracilderivate als Liganden der Thyroidrezeptoren
ES2267945T3 (es) 2001-05-31 2007-03-16 Pfizer Products Inc. Uso medico de compuestos tiromimeticos para tratar la perdida del cabello y composiciones.
ATE480524T1 (de) 2005-07-21 2010-09-15 Hoffmann La Roche Pyridazinonderivate als schilddrüsenhormon- rezeptoragonisten
US8076334B2 (en) 2007-09-20 2011-12-13 Hoffmann-La Roche Inc. Prodrugs of thyroid hormone analogs
KR101396606B1 (ko) * 2009-04-20 2014-05-16 미쓰비시 타나베 파마 코퍼레이션 신규 갑상선 호르몬 β 수용체 작동약
JP5847533B2 (ja) * 2010-10-19 2016-01-27 田辺三菱製薬株式会社 新規甲状腺ホルモンβ受容体作動薬
CN109574995B (zh) 2018-01-23 2020-07-24 深圳市塔吉瑞生物医药有限公司 取代的哒嗪酮化合物
ES3029158T3 (en) 2018-06-12 2025-06-23 Xizang Haisco Pharmaceutical Co Ltd Thyroid hormone receptor agonists and uses thereof
CN119431265A (zh) * 2019-02-21 2025-02-14 南京瑞捷医药科技有限公司 一种作为甲状腺激素受体激动剂的化合物
MX2022008626A (es) 2020-01-13 2022-08-22 Eccogene Shanghai Co Ltd Triazinonas sustituidas como agonistas del receptor de la hormona tiroidea.
EP4167986A4 (en) * 2020-06-17 2024-11-20 Autobahn Therapeutics, Inc. THYROMIMETICS

Similar Documents

Publication Publication Date Title
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2018516243A5 (cg-RX-API-DMAC7.html)
JP2021535207A5 (cg-RX-API-DMAC7.html)
WO2018013597A4 (en) 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
JP2016518437A5 (cg-RX-API-DMAC7.html)
IL268030B2 (en) Bicyclics as allosteric shp2 inhibitors
JP2018538248A5 (cg-RX-API-DMAC7.html)
JP2018511628A5 (cg-RX-API-DMAC7.html)
JP2015500887A5 (cg-RX-API-DMAC7.html)
JP2015532295A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP2019521109A5 (cg-RX-API-DMAC7.html)
JP2019529444A5 (cg-RX-API-DMAC7.html)
JP2014503574A5 (cg-RX-API-DMAC7.html)
RU2017107559A (ru) Лечение раковых заболеваний с применением анти-nkg2a средств
RU2010145177A (ru) Лекарственное средство для лечения рака печени
JP2021510733A5 (cg-RX-API-DMAC7.html)
JP2015536997A5 (cg-RX-API-DMAC7.html)
JP2019520344A5 (cg-RX-API-DMAC7.html)
US20220117935A1 (en) Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
PH12022550441A1 (en) Azaheteroaryl compound and application thereof
JP2022508513A5 (cg-RX-API-DMAC7.html)
JP2020531414A5 (cg-RX-API-DMAC7.html)
JP2020517619A5 (cg-RX-API-DMAC7.html)
WO2016025474A1 (en) Methods of treating pulmonary hypertension